Akanda Corp. (NASDAQ:AKAN – Get Free Report) was the target of a significant decrease in short interest in the month of June. As of June 30th, there was short interest totaling 18,178 shares, a decrease of 87.0% from the June 15th total of 139,841 shares. Currently, 4.2% of the company’s stock are sold short. Based on an average daily volume of 44,335 shares, the days-to-cover ratio is presently 0.4 days.
Analysts Set New Price Targets
A number of research firms have recently weighed in on AKAN. Weiss Ratings downgraded shares of Akanda from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Monday, May 18th. Wall Street Zen raised shares of Akanda to a “sell” rating in a report on Saturday, May 30th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has an average rating of “Sell”.
Read Our Latest Stock Report on Akanda
Akanda Stock Down 1.1%
Akanda (NASDAQ:AKAN – Get Free Report) last issued its earnings results on Tuesday, June 9th. The company reported ($317.90) EPS for the quarter.
Akanda Company Profile
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
See Also
- Five stocks we like better than Akanda
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Receive News & Ratings for Akanda Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akanda and related companies with MarketBeat.com's FREE daily email newsletter.
